Anticancer drug discovery: Embracing the next wave of innovation

Anticancer drug discovery has evolved with accelerated FDA and NMPA approvals of novel agents, expanded therapeutic options beyond traditional cytotoxic drugs, and a shift towards precision oncology informed by tumor biology. The next wave of innovation focuses on systems-level understanding of tumors, new therapeutic modalities, and emerging molecular mechanisms driving cancer malignancy and drug resistance.

This Wire brief sits within Fusion42's coverage of Drug Discovery, Biotech and Medtech.